Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning-Reference-Cited by-同舟云学术

Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning

Published:2003-04-28 Issue:3 Volume:121 Page:411-418
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Einsele Hermann,Schäfer Hans-Jörg,Hebart Holger,Bader Peter,Meisner Christoph,Plasswilm Ludwig,Liebisch Peter,Bamberg Michael,Faul Christoph,Kanz Lothar

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04299.x/fullpdf

Reference29 articles.

1. A prospective, randomised trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;New England Journal of Medicine,1996

2. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows prediction of relapse after allogeneic BMT;Bader;Bone Marrow Transplantation,1998

3. High response rate in refractory and poor-risk multiple myeloma after allotransplantation using a non-myeloablative conditioning regimen and donor lymphocyte infusion;Badros;Blood,2001

4. High-dose melphalan with autologous bone marrow transplantation for multiple myeloma;Barlogie;Blood,1986

5. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma;Barlogie;Blood,1997

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic stem cell transplantation in patients with multiple myeloma-single center experience;Neoplasma;2023

2. Allogeneic Transplantation in Multiple Myeloma—Does It Still Have a Place?;Journal of Clinical Medicine;2020-07-10

3. Rezidivtherapie des Multiplen Myeloms – Individualisierte Konzepte aus dem Arsenal vielfältiger Optionen;DMW - Deutsche Medizinische Wochenschrift;2020-06

4. Graft-Versus-Host Disease in Multiple Myeloma Patients Treated With Daratumumab After Allogeneic Transplantation;Clinical Lymphoma Myeloma and Leukemia;2020-06

5. Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life;Haematologica;2018-09-20